- Home
- EPIX vs BYSI Comparison
EPIX vs BYSI Comparison
Compare EPIX & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- BYSI
- Stock Information
- Founded
- EPIX 2009
- BYSI 2010
- Country
- EPIX Canada
- BYSI United States
- Employees
- EPIX N/A
- BYSI N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- EPIX Health Care
- BYSI Health Care
- Exchange
- EPIX Nasdaq
- BYSI Nasdaq
- Market Cap
- EPIX 65.3M
- BYSI 72.1M
- IPO Year
- EPIX N/A
- BYSI 2017
- Fundamental
- Price
- EPIX $1.79
- BYSI $1.31
- Analyst Decision
- EPIX Hold
- BYSI
- Analyst Count
- EPIX 3
- BYSI 0
- Target Price
- EPIX $2.00
- BYSI N/A
- AVG Volume (30 Days)
- EPIX 186.2K
- BYSI 24.5K
- Earning Date
- EPIX 05-13-2025
- BYSI 01-01-0001
- Dividend Yield
- EPIX N/A
- BYSI N/A
- EPS Growth
- EPIX N/A
- BYSI N/A
- EPS
- EPIX N/A
- BYSI N/A
- Revenue
- EPIX N/A
- BYSI N/A
- Revenue This Year
- EPIX N/A
- BYSI N/A
- Revenue Next Year
- EPIX N/A
- BYSI N/A
- P/E Ratio
- EPIX N/A
- BYSI N/A
- Revenue Growth
- EPIX N/A
- BYSI N/A
- 52 Week Low
- EPIX $1.40
- BYSI $0.98
- 52 Week High
- EPIX $7.88
- BYSI $3.63
- Technical
- Relative Strength Index (RSI)
- EPIX 69.44
- BYSI 44.17
- Support Level
- EPIX $1.42
- BYSI $1.03
- Resistance Level
- EPIX $1.88
- BYSI $1.27
- Average True Range (ATR)
- EPIX 0.10
- BYSI 0.15
- MACD
- EPIX 0.03
- BYSI 0.00
- Stochastic Oscillator
- EPIX 81.32
- BYSI 48.53
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.